‹ All stocks
Liminatus Pharma, Inc. Class A Common Stock
LIMN · NASDAQ · Healthcare
$3.89
▲ $3.89 (2.37%)
Day range
$3.78 – $3.94
Year range
$0.10 – $5.88
Open
$3.80
Previous close
—
Market cap
$5.23M
Volume (24h)
$4.6K
Volume (52w)
$17.74K
Performance
7D
▼ -8.90%
1M
▲ 7.46%
3M
▲ 2903.86%
6M
▲ 2014.13%
1Y
▲ 124.86%
YTD
▲ 507.15%
3Y
▼ -61.37%
5Y
▼ -61.37%
All-time
▼ -61.37%
Key statistics
P/E ratio
-2.39
EPS (TTM)
$-1.63
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
1.3M
About Liminatus Pharma, Inc. Class A Common Stock
Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.
Visit websiteCountry: United States of America
More in Healthcare
LLY Eli Lilly and Company |
$1143.12 | -0.59% |
JNJ Johnson & Johnson |
$252.93 | -2.22% |
ABBV AbbVie |
$265.76 | 2.20% |
MRK Merck & Co. |
$139.54 | -2.97% |
UNH UnitedHealth Group Incorp… |
$378.58 | 3.66% |